Eflornithine hydrochloride cream 13.9% (Vaniqa - Bristol-Myers Squibb) has been approved by the FDA for reduction of unwanted facial hair in women....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to
The Medical Letter on Drugs and Therapeutics, please
login or
register to view it online.
If you have already purchased this article, or have a subscription to
The Medical Letter on Drugs and Therapeutics, please
login or
register to view it online.
Information about the article:
Title: Eflornithine Cream For Facial Hair Reduction
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1089
Article Code: 1089c
Date: October 2, 2000
Volume: 42
Page: 96